Squarepoint
AGTC

Squarepoint’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Squarepoint’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,288
Closed -$29K – 3806
2021
Q4 		$29K Sell
15,288
-42,247
-73% -$101K ﹤0.01% 3073
2021
Q3 		$173K Sell
57,535
-95,590
-62% -$340K ﹤0.01% 2541
2021
Q2 		$599K Buy
153,125
+64,290
+72% +$267K ﹤0.01% 2009
2021
Q1 		$450K Buy
88,835
+25,733
+41% +$134K ﹤0.01% 2103
2020
Q4 		$258K Sell
63,102
-45,579
-42% -$224K ﹤0.01% 2330
2020
Q3 		$528K Buy
108,681
+14,285
+15% +$78K 0.01% 1397
2020
Q2 		$523K Sell
94,396
-37,848
-29% -$173K 0.01% 1295
2020
Q1 		$434K Buy
132,244
+42,862
+48% +$226K 0.01% 1117
2019
Q4 		$404K Sell
89,382
-4,418
-5% -$14K ﹤0.01% 1889
2019
Q3 		$390K Buy
93,800
+27,274
+41% +$98.5K ﹤0.01% 1747
2019
Q2 		$252K Buy
66,526
+52,098
+361% +$214K ﹤0.01% 2000
2019
Q1 		$60K Buy
+14,428
New +$50.4K ﹤0.01% 2073
2018
Q2 		– Sell
-13,800
Closed -$53K – 2149
2018
Q1 		$53K Sell
13,800
-3,100
-18% -$13K ﹤0.01% 1610
2017
Q4 		$61K Sell
16,900
-28,800
-63% -$109K ﹤0.01% 2000
2017
Q3 		$181K Buy
45,700
+22,089
+94% +$101K ﹤0.01% 1414
2017
Q2 		$120K Buy
23,611
+6,507
+38% +$36.5K ﹤0.01% 1385
2017
Q1 		$118K Sell
17,104
-5,321
-24% -$41.6K ﹤0.01% 1389
2016
Q4 		$210K Buy
+22,425
New +$202K 0.01% 1406

Other funds holding AGTC

CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Squarepoint's AGTC Position: Q1 2022 in Review

Squarepoint sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2022, closing a stake of 15,288 shares — an estimated $29K sold.

Squarepoint first reported a position in AGTC in Q4 2016 and held it in 18 quarters. The position peaked at $599K in Q2 2021. 53 funds tracked by Wall St. Rank hold AGTC as of Q1 2022.

  • Squarepoint reported no remaining Applied Genetic Technologies Corporation position as of Q1 2022 after selling out during the quarter.
  • Squarepoint sold 15,288 Applied Genetic Technologies Corporation shares in Q1 2022, an estimated $29K.
  • Squarepoint first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 18 quarters.
  • Squarepoint's Applied Genetic Technologies Corporation position peaked at $599K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.